In summary, this study demonstrated that miR-181a targets SRCIN1 to promote CRC angiogenesis, and we further identified the miR-181a–SRCIN1–SRC–VEGF axis in CRC (the working model is shown in Fig. 6f). The gene discussed is SRCIN1; the disease is colorectal carcinoma.